Back to all Programs

Past Event

Related Materials

Past Event

International Workshop on HBV Cure 2017

Viral Hepatitis and Liver Disease

TAF – The latest update, which questions remain to be answered? | Pietro Lampertico, MD, PhD

Viral Hepatitis and Liver Disease

Hepatitis B Cure: From Discovery to Regulatory Endpoints in HBV clinical research: A summary of the AASLD/EASL statement | Fabien Zoulim, MD, PhD

Viral Hepatitis and Liver Disease

Is immunomodulation really needed to cure HBV? | Harry Janssen, MD, PhD

Viral Hepatitis and Liver Disease

How does HBV interact with the immune system | Mala Maini, MD, PhD

Viral Hepatitis and Liver Disease

Innate Immunity : TLR, RIG-I, STING and potential others | Adam Gehring, PhD

Viral Hepatitis and Liver Disease

CCC – DNA inhibition | Anuj Gaggar, MD, PhD

Viral Hepatitis and Liver Disease

RNA interference | Bill Symonds, PharmD

Viral Hepatitis and Liver Disease

HBV Ribonuclease H | John Tavis, PhD

Viral Hepatitis and Liver Disease

Other virological mechanisms | Stephen Locarnini, BSc, PhD, MBBS, FRCP

Viral Hepatitis and Liver Disease

Combination therapy how to navigate in a minefield of efficacy and toxicity? | Jordan Feld, MD, MPH

Viral Hepatitis and Liver Disease

Innovative trial design | Henry Lik Yuen Chan

Viral Hepatitis and Liver Disease

Roundtable discussion: Trial design, treatment endpoints and regulatory approach